Table 1 Clinical characteristics of hospitalized patients
Clinical characteristics | Total n = 114 | Colistin-resistance | p-value | |
|---|---|---|---|---|
Yes n = 32 | No n = 82 | |||
Age [median (IQR)] | 56 (29–72) | 61 (28–73) | 50 (29–71) | 0.297 |
Sex [n (%)] | ||||
Female | 40 (35.09) | 8 (25) | 32 (39.02) | 0.159 |
Male | 74 (64.91) | 24 (75) | 50 (60.98) | |
Charlson [median (IQR)] | 2 (0–4) | 2 (1–6) | 2 (0–3) | 0.143 |
APACHE [median (IQR)] | 15 (9–21) | 16 (13–22) | 15 (6–21) | 0.201 |
Diagnostic [n (%)] | ||||
Neurological disease | 35 (30.97) | 11 (35.48) | 24 (29.27) | 0.524 |
Acute respiratory failure | 24 (21.05) | 6 (18.75) | 18 (21.95) | 0.706 |
Chronic heart failure | 14 (12.28) | 5 (15.63) | 9 (10.98) | 0.532 |
Renal failure | 17 (14.91) | 9 (28.13) | 8 (9.76) | 0.020a |
Diabetes mellitus | 13 (11.4) | 5 (15.63) | 8 (9.76) | 0.512 |
Immunosuppresion | 13 (11.61) | 3 (9.68) | 10 (12.35) | 1.000 |
Gastrointestinal disease | 11 (9,65) | 2 (6.25) | 9 (10.98) | 0.725 |
Malignancy | 8 (7.02) | 3 (9.38) | 5 (6.1) | 0.684 |
Polytrauma | 7 (6.14) | 3 (9.38) | 4 (4.88) | 0.399 |
Sepsis | 6 (5.26) | 1 (3.13) | 5 (6.1) | 1.000 |
Comorbidities [n (%)] | ||||
Renal failure | 28 (24.78) | 12 (38.71) | 16 (19.51) | 0.035a |
Chronic heart failure | 51 (45.13) | 17 (54.84) | 34 (41.46) | 0.202 |
Diabetes mellitus | 32 (28.57) | 11 (35.48) | 21 (25.93) | 0.316 |
Malignancy | 17 (15.04) | 6 (19.35) | 11 (13.41) | 0.556 |
Neurological disease | 16 (14.16) | 2 (6.45) | 14 (17.07) | 0.227 |
Immunosuppresion | 13 (11.5) | 2 (6.45) | 11 (13.41) | 0.509 |
Chronic pulmonar disease | 4 (3.6) | 1 (3.23) | 3 (3.75) | 1.000 |
Length of hospital stay [median (IQR)] | 39 (20–156) | 44 (21–124) | 38 (19–158) | 0.709 |
Mortality [n (%)] | 47 (41.23) | 14 (43.75) | 33 (40.24) | 0.733 |